Goldman Sachs led in advisory value with $23.8bn in transactions, while PwC topped in deal volume with 52 transactions.

ViiV's Cabenuva is administered every two months and was offered to HIV patients who achieved viral suppression from daily treatments.

Medtronic has secured EU CE mark approval for LigaSure RAS, a vessel-sealing instrument for use with the company’s Hugo robotic-assisted surgery (RAS) system.

Experian (EXPN), Barratt Redrow (BTRW), B&M European Value (BME), GlobalData (DATA), Robert Walters (RWA), Mobico (MCG), ...

BEIJING (Reuters) -Chinese state firm employee Zhang Jinming makes up for a 24% cut to his salary by delivering food for ...

Artificial intelligence, robotics and the Internet of Things (IoT) are no longer futuristic concepts—they are reshaping how consumer brands operate, engage and grow. As these technologies move from ...

The US Food and Drug Administration (FDA) has cleared Caranx Medical’s TAVIPILOT Soft, an artificial intelligence (AI)-based guide software for use during Transcatheter Aortic Valve Implantation (TAVI ...

JP Morgan and Houlihan Lokey have led the mergers and acquisitions (M&A) rankings for financial advisers in North America for ...

According to preliminary estimates, US Light Vehicle (LV) sales fell by 4.3% YoY in June, to 1.26 million units, reports GlobalData.

Both AstraZeneca and MSD have tied lucrative licensing deals for two of LaNova’s oncology assets in recent years.

The US dominates overall sales, yet GlobalData predicts that China is shaping up to be a formidable presence in the cell therapy space.

China’s LV market continued its strong performance in May 2025, with sales rising by 10% YoY to approximately 2.1 million units, reports GlobalData.